Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
McKenzie J et al. Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. 2006 Clin. Endocrinol. (Oxf) pmid:16817817
Kurtay G et al. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women. 2006 Maturitas pmid:16325022
Huber J and Walch K Treating acne with oral contraceptives: use of lower doses. 2006 Contraception pmid:16371290
Bergstrøm H and Tonstad S Combined hormone replacement therapy improves lipids but may increase leucocytes. 2006 J. Intern. Med. pmid:16629858
Hemelaar M et al. Less effect of intranasal than oral hormone therapy on factors associated with venous thrombosis risk in healthy postmenopausal women. 2006 Arterioscler. Thromb. Vasc. Biol. pmid:16645152
Wilfong AA and Willmore LJ Zonisamide - a review of experience and use in partial seizures. 2006 Neuropsychiatr Dis Treat pmid:19412474
Koundi KL et al. Quality of life and psychological symptoms in Greek postmenopausal women: association with hormone therapy. 2006 Gynecol. Endocrinol. pmid:17162707
Franke HR et al. Treatment of dysfunctional uterine bleeding in the perimenopause: the effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment--a randomized, placebo-controlled, double-blind trial. 2006 Gynecol. Endocrinol. pmid:17162712
Stranahan D et al. The role of intradermal skin testing and patch testing in the diagnosis of autoimmune progesterone dermatitis. 2006 Dermatitis pmid:16800278
Eigeliene N et al. Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures. 2006 BMC Cancer pmid:17044944
Arruda CG et al. Effects of estradiol alone and combined with norethisterone acetate on pulse-wave velocity in hypertensive postmenopausal women. 2006 Gynecol. Endocrinol. pmid:17135035
Seeger H et al. Is there a protective role of progestogens on the proliferation of human ovarian cancer cells in the presence of growth factors? 2006 Eur. J. Gynaecol. Oncol. pmid:16620055
Yildirim G et al. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding. 2006 Arch. Gynecol. Obstet. pmid:16315025
Morroni C et al. Preferences between injectable contraceptive methods among South African women. 2006 Contraception pmid:16730491
Smith YR et al. Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging. 2006 J. Clin. Endocrinol. Metab. pmid:16912129
Maclaughlin EJ et al. Management of age-related osteoporosis and prevention of associated fractures. 2006 Ther Clin Risk Manag pmid:18360603
Jordan N et al. Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women. 2006 Clin Interv Aging pmid:18046915
Mazzoni CJ et al. Molecular polymorphism, differentiation and introgression in the period gene between Lutzomyia intermedia and Lutzomyia whitmani. 2006 BMC Evol. Biol. pmid:17069656
Seidel A et al. Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control. 2006 Br. J. Cancer pmid:16685264
Abdullah A et al. Studies on the synthesis, characterization, binding with DNA and activities of two cis-planaramineplatinum(II) complexes of the form: cis-PtL(NH3)Cl2 where L = 3-hydroxypyridine and 2,3-diaminopyridine. 2006 BMC Chem Biol pmid:16533399
Pedersen SH et al. Medroxyprogesterone acetate attenuates long-term effects of 17beta-estradiol in coronary arteries from hyperlipidemic rabbits. 2006 Steroids pmid:16815506
Christodoulakos GE et al. The effect of low dose hormone therapy on mammographic breast density. 2006 Maturitas pmid:16198519
Thunell L et al. The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes. 2006 Maturitas pmid:16198072
Kalleinen N et al. Sleep deprivation and hormone therapy in postmenopausal women. 2006 Sleep Med. pmid:16815746
Ayotte C Significance of 19-norandrosterone in athletes' urine samples. 2006 Br J Sports Med pmid:16799098
Genazzani AR et al. Beneficial effect of tibolone on mood, cognition, well-being, and sexuality in menopausal women. 2006 Neuropsychiatr Dis Treat pmid:19412477
Peverill RE et al. Comparison of effects of pravastatin and hormone therapy on soluble P-selectin and platelet P-selectin expression in postmenopausal hypercholesterolemic women. 2006 Maturitas pmid:16368469
Popp AW et al. Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy. 2006 Maturitas pmid:16368472
Cagnacci A et al. Tibolone and estradiol plus norethisterone acetate similarly influence endothelium-dependent vasodilatation in healthy postmenopausal women. 2006 Fertil. Steril. pmid:16806211
Rowan JP et al. Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials. 2006 Clin Ther pmid:16860174
Watanabe K et al. Effects of progesterone and norethisterone on cephalexin transport and peptide transporter PEPT1 expression in human intestinal cell line Caco-2. 2006 Biol. Pharm. Bull. pmid:16394517
Djerassi C Chemical birth of the pill. 1992. 2006 Am. J. Obstet. Gynecol. pmid:16389046
Dickey CA et al. Pharmacologic reductions of total tau levels; implications for the role of microtubule dynamics in regulating tau expression. 2006 Mol Neurodegener pmid:16930453
Van Vliet HA et al. Biphasic versus monophasic oral contraceptives for contraception. 2006 Cochrane Database Syst Rev pmid:16855983
Van Vliet HA et al. Biphasic versus triphasic oral contraceptives for contraception. 2006 Cochrane Database Syst Rev pmid:16856002
van Vliet HA et al. Triphasic versus monophasic oral contraceptives for contraception. 2006 Cochrane Database Syst Rev pmid:16856013
Zegura B et al. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women. 2006 Jul-Aug Menopause pmid:16837886
Bese T et al. The effect of long-term use of progesterone therapy on proliferation and apoptosis in simple endometrial hyperplasia without atypia. 2006 Mar-Apr Int. J. Gynecol. Cancer pmid:16681766
Batzer FR GnRH analogs: options for endometriosis-associated pain treatment. 2006 Nov-Dec J Minim Invasive Gynecol pmid:17097577
Qoubaitary A et al. Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men. 2006 Nov-Dec J. Androl. pmid:16837736
Manoharan C et al. The role of charged residues in the transmembrane helices of monocarboxylate transporter 1 and its ancillary protein basigin in determining plasma membrane expression and catalytic activity. 2006 Nov-Dec Mol. Membr. Biol. pmid:17127621
Soares CN et al. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. 2006 Sep-Oct Menopause pmid:16894334
Rachoń D et al. Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women. 2006 Sep-Oct Menopause pmid:16894332
Haider S and Darney PD Injectable contraception. 2007 Clin Obstet Gynecol pmid:17982332
Xu B et al. Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells. 2007 Maturitas pmid:16962266
Chu MC et al. Formation of ethinyl estradiol in women during treatment with norethindrone acetate. 2007 J. Clin. Endocrinol. Metab. pmid:17341557
Schaudig K and Thomssen C Hormonal therapy with patch or pill: how much does it matter? 2007 Thromb. Haemost. pmid:17393010
Brosnan JF et al. Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration? 2007 Thromb. Haemost. pmid:17393018
Gorenoi V et al. Benefits and risks of hormonal contraception for women. 2007 GMS Health Technol Assess pmid:21289940
Chrisp P Aprepitant: the evidence for its place in the prevention of chemotherapy-induced nausea and vomiting. 2007 Core Evid pmid:21221195
Grover S et al. Pharmacoprophylaxis of alcohol dependence: Review and update Part I: Pharmacology. 2007 Indian J Psychiatry pmid:20640061
Guazzelli CA et al. Monthly injectable contraceptive use by adolescents in Brazil: evaluation of clinical aspects. 2007 Contraception pmid:17586136
Samsioe G et al. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women. 2007 Maturitas pmid:17317046
Savidge TC et al. Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione. 2007 Gastroenterology pmid:17408650
Fonseca AM et al. Monophasic estrogen-progestogen therapy and sexuality in postmenopausal women. 2007 Clin Drug Investig pmid:17217318
Keramaris NC et al. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women. 2007 Climacteric pmid:17852143
Ghoneim MM et al. Voltammetry and quantification of the contraceptive drug norethisterone in bulk form and pharmaceutical formulation. 2007 J Pharm Biomed Anal pmid:16950587
Bonassi Machado R et al. Effects of estrogen and estrogen-progestogen therapy on homocysteine levels and their correlation with carotid vascular resistance. 2007 Gynecol. Endocrinol. pmid:17907004
Seeger H et al. In vitro effects of tibolone and its metabolites on human vascular coronary cells. 2007 Maturitas pmid:17572028
Abdallah MA et al. Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro study. 2007 Fertil. Steril. pmid:17207794
Raobaikady B et al. Tibolone and its delta-4, 7alpha-methyl norethisterone metabolite are reversible inhibitors of human aromatase. 2007 J. Steroid Biochem. Mol. Biol. pmid:17467267
Dane C et al. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis. 2007 Gynecol. Endocrinol. pmid:17701771
Myer L et al. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. 2007 Int J Epidemiol pmid:17175547
Leavis HL et al. Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium. 2007 PLoS Pathog. pmid:17257059
Christodoulakos GE et al. Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene. 2007 Atherosclerosis pmid:16842799
Lundström E et al. Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density. 2007 Climacteric pmid:17487652
Kuhl H and Wiegratz I Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications? 2007 Climacteric pmid:17653961
Pham VL et al. Aminopeptidase B, a glucagon-processing enzyme: site directed mutagenesis of the Zn2+-binding motif and molecular modelling. 2007 BMC Biochem. pmid:17974014
Rekhi B et al. A unique RET EXON 11 (G691S) polymorphism in an Indian patient with a collision tumor of the thyroid. 2007 Diagn Pathol pmid:17939859
Licea-Perez H et al. A semi-automated 96-well plate method for the simultaneous determination of oral contraceptives concentrations in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry. 2007 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:17258945
Schrettl M et al. Distinct roles for intra- and extracellular siderophores during Aspergillus fumigatus infection. 2007 PLoS Pathog. pmid:17845073
Hansen A et al. Developments in lupus 2006. 2007 Arthritis Res. Ther. pmid:17634152
Muralidhar KR et al. Measurement of back-scattered radiation from micro multileaf collimator into the beam monitor chamber from a dual energy linear accelerator. 2007 J Med Phys pmid:21157537
Yokozeki T et al. Meltrin beta (ADAM19) mediates ectodomain shedding of Neuregulin beta1 in the Golgi apparatus: fluorescence correlation spectroscopic observation of the dynamics of ectodomain shedding in living cells. 2007 Genes Cells pmid:17352738
Kluger G and Bauer B Role of rufinamide in the management of Lennox-Gastaut syndrome (childhood epileptic encephalopathy). 2007 Neuropsychiatr Dis Treat pmid:19300535
Joshi S et al. Ovarian gene expression in the absence of FIGLA, an oocyte-specific transcription factor. 2007 BMC Dev. Biol. pmid:17567914
Barton M et al. Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits? 2007 Arterioscler. Thromb. Vasc. Biol. pmid:17634518
Tugrul S et al. Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects. 2007 Arch. Gynecol. Obstet. pmid:17051405
Cédrin-Durnerin I et al. Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. 2007 Hum. Reprod. pmid:16936304
Sherwood A et al. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. 2007 Arterioscler. Thromb. Vasc. Biol. pmid:17541023
Kurtay G and Ozmen B A comparison of the effects of sequential transdermal versus continuous orally administered hormone replacement therapies on plasma total homocysteine levels in postmenopausal women: a randomized, placebo-controlled study. 2007 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:16814449
Remorgida V et al. Letrozole and norethisterone acetate in rectovaginal endometriosis. 2007 Fertil. Steril. pmid:17331508
Su L and Turner JR Got guts? Need nerve! 2007 Gastroenterology pmid:17418164
Syed V et al. Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression. 2007 J. Cell. Biochem. pmid:17393432
Fernandez MP et al. An assessment of estrogenic organic contaminants in Canadian wastewaters. 2007 Sci. Total Environ. pmid:17197011
Beksinska ME et al. Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception. 2007 Contraception pmid:17519149
Kleinschmidt I et al. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. 2007 Contraception pmid:17519153
Palin SL et al. Dydrogesterone and norethisterone regulate expression of lipoprotein lipase and hormone-sensitive lipase in human subcutaneous abdominal adipocytes. 2007 Diabetes Obes Metab pmid:17587400
Kernohan AF et al. Effects of low-dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes. 2007 Clin. Endocrinol. (Oxf) pmid:17201798
Enríquez J et al. The effects of synthetic 19-norprogestins on osteoblastic cell function are mediated by their non-phenolic reduced metabolites. 2007 J. Endocrinol. pmid:17535886
Rosenberg L et al. Bone status after cessation of use of injectable progestin contraceptives. 2007 Contraception pmid:18061699
Bjarnason NH et al. The influence of smoking on uterine bleeding during continuous and interrupted oral hormone therapy. 2007 Climacteric pmid:18049941
Divasta AD et al. Bone density in adolescents treated with a GnRH agonist and add-back therapy for endometriosis. 2007 J Pediatr Adolesc Gynecol pmid:17868896
Guo Z et al. Development of a high-performance liquid chromatographic method for the determination of mifepristone in human plasma using norethisterone as an internal standard: application to pharmacokinetic study. 2007 Contraception pmid:17707721
Panay N et al. Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief. 2007 Climacteric pmid:17453860
Hofling M et al. Testosterone addition during menopausal hormone therapy: effects on mammographic breast density. 2007 Climacteric pmid:17453864
Sgarabotto M et al. Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study. 2007 Thromb. Res. pmid:16499954
Yüksel H et al. Effects of postmenopausal hormone replacement therapy on body fat composition. 2007 Gynecol. Endocrinol. pmid:17454160
Verhoeven MO et al. Effects of intranasal versus oral hormone therapy on asymmetric dimethylarginine in healthy postmenopausal women: a randomized study. 2007 Atherosclerosis pmid:17084844
Duvernoy CS et al. Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study. 2007 J Womens Health (Larchmt) pmid:17903073